Tibsovo (ivosidenib) - Servier
hemagenleukleucel (Hem101) - National Medical Research Center for Hematology
Rezlidhia (olutasidenib) - Rigel
https://clml-25-01.elsevierdigitaledition.com/
 
Justin Watts MD 1; Brian A. Jonas MD, PhD 2; Eunice S. Wang MD 3; Florence R. Wilson MS 4; Julie Park MMath 4; Shannon Cope MS 4; Aaron D. Sheppard PhD 5; Stéphane de Botton MD, PhD 6; Jorge Cortes MD 7
 
Aug 26, 2025
 
Next